Cramer: Gilead Is Dead Money

Jim Cramer said on CNBC's "Mad Money" that Gilead Sciences, Inc. GILD is "dead money." He can't think of a reason to buy it. Cramer thinks that selling at $67 "seems wrong," but he sees no catalyst to buy it.

Las Vegas Sands Corp. LVS is a good company, said Cramer. He advised his viewer to hold the stock. It's trading at its 52-week high, but Cramer is a buyer at the current price level.

Related Links:

Benzinga's Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time

Gilead Sciences Q1 2018 Financial Results